Gi Mo Jung

Title: Gi Mo Jung: Innovator in Antibacterial Proteins

Introduction

Gi Mo Jung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial proteins. With a total of 4 patents to his name, Jung is recognized for his innovative approaches to combating bacterial infections.

Latest Patents

Among his latest patents, Jung has developed an antibacterial protein that exhibits lytic activity against specific genera. This invention includes a method for preparing the antibacterial protein, which involves culturing BL21-pBAD-BAL200 cells that contain a plasmid with a specific sequence. The process includes inducing the expression of the antibacterial protein and purifying it for use. Another notable patent is for the antibacterial protein EFAL-2, derived from the bacteriophage Ent-FAP-4. This protein has demonstrated the ability to kill bacteria and is included in a pharmaceutical composition aimed at preventing or treating diseases caused by bacterial infections.

Career Highlights

Gi Mo Jung is currently employed at Intron Biotechnology, Inc., where he continues to advance his research in antibacterial solutions. His work has positioned him as a key figure in the biotechnology sector, contributing to the development of effective treatments against bacterial pathogens.

Collaborations

Jung collaborates with talented colleagues, including Seong Jun Yoon and Soo Youn Jun, who share his commitment to innovation in biotechnology. Their combined efforts enhance the research and development capabilities of their organization.

Conclusion

Gi Mo Jung's contributions to the field of antibacterial proteins highlight his role as an influential inventor in biotechnology. His innovative patents and ongoing research efforts are paving the way for new solutions to combat bacterial infections.